Li Jin, Berbeco Ross, Distel Robert J, Jänne Pasi A, Wang Lilin, Makrigiorgos G Mike
Division of Genomic Stability and DNA Repair, Department of Radiation Oncology, Dana Farber-Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA, USA.
Nucleic Acids Res. 2007;35(12):e84. doi: 10.1093/nar/gkm403. Epub 2007 Jun 1.
The rapidly growing understanding of human genetic pathways, including those that mediate cancer biology and drug response, leads to an increasing need for extensive and reliable mutation screening on a population or on a single patient basis. Here we describe s-RT-MELT, a novel technology that enables highly expanded enzymatic mutation scanning in human samples for germline or low-level somatic mutations, or for SNP discovery. GC-clamp-containing PCR products from interrogated and wild-type samples are hybridized to generate mismatches at the positions of mutations over one or multiple sequences in-parallel. Mismatches are converted to double-strand breaks using a DNA endonuclease (Surveyor) and oligonucleotide tails are enzymatically attached at the position of mutations. A novel application of PCR enables selective amplification of mutation-containing DNA fragments. Subsequently, melting curve analysis, on conventional or nano-technology real-time PCR platforms, detects the samples that contain mutations in a high-throughput and closed-tube manner. We apply s-RT-MELT in the screening of p53 and EGFR mutations in cell lines and clinical samples and demonstrate its advantages for rapid, multiplexed mutation scanning in cancer and for genetic variation screening in biology and medicine.
对人类遗传途径(包括那些介导癌症生物学和药物反应的途径)的快速深入了解,使得在群体或个体患者层面进行广泛且可靠的突变筛查的需求日益增加。在此,我们描述了s-RT-MELT,这是一种新技术,能够在人类样本中对种系或低水平体细胞突变进行高度扩展的酶促突变扫描,或用于单核苷酸多态性(SNP)发现。来自检测样本和野生型样本的含GC夹的PCR产物进行杂交,以在一个或多个平行序列的突变位置产生错配。使用DNA内切酶(Surveyor)将错配转化为双链断裂,并在突变位置酶促连接寡核苷酸尾巴。PCR的一种新应用能够选择性扩增含突变的DNA片段。随后,在传统或纳米技术实时PCR平台上进行熔解曲线分析,以高通量和闭管方式检测含有突变的样本。我们将s-RT-MELT应用于细胞系和临床样本中p53和EGFR突变的筛查,并证明了其在癌症中快速、多重突变扫描以及生物学和医学中遗传变异筛查方面的优势。